Leading the way to safer medication
 Crosscheck  Recommender

Anastrozole

Description

Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor. It inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens. Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women.

ATC Classification

Code
Title
Category
L02BG03
Anastrozole
L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors

Trade names

Trade name
Countries

Spain

Australia

Austria

Singapore

Singapore

Singapore

Cyprus Singapore

Australia

Australia Austria Canada Cyprus France

Singapore

Singapore

Cyprus

Cyprus

Product Monographs

Monograph
Type
Country
ARIMIDEX Film-coated tablets
MPI, EU: SmPC
UK